Whole Exome Sequencing Identifies Novel DYT1 Dystonia- 2 Associated Genome Variants As Potential Disease Modifiers 3 4 Chih-Fen Hu1*, G

Total Page:16

File Type:pdf, Size:1020Kb

Whole Exome Sequencing Identifies Novel DYT1 Dystonia- 2 Associated Genome Variants As Potential Disease Modifiers 3 4 Chih-Fen Hu1*, G bioRxiv preprint doi: https://doi.org/10.1101/2020.03.15.993113; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Whole exome sequencing identifies novel DYT1 dystonia- 2 associated genome variants as potential disease modifiers 3 4 Chih-Fen Hu1*, G. W. Gant Luxton2, Feng-Chin Lee1, Chih-Sin Hsu3, Shih-Ming 5 Huang4, Jau-Shyong Hong5, San-Pin Wu6* 6 7 1 Department of Pediatrics, Tri-Service General Hospital, National Defense Medical 8 Center, Taipei, Taiwan 9 2 Department of Genetics, Cell Biology, and Development, University of Minnesota, 10 Minneapolis, MN, United States 11 3 Center for Precision Medicine and Genomics, Tri-Service General Hospital, 12 National Defense Medical Center, Taipei, Taiwan 13 4 Department and Graduate Institute of Biochemistry, National Defense Medical 14 Center, Taipei, Taiwan 15 5 Neurobiology Laboratory, National Institute of Environmental Health Sciences, 16 National Institutes of Health, Research Triangle Park, NC, United States 17 6 Reproductive and Developmental Biology Laboratory, National Institute of 18 Environmental Health Sciences, National Institutes of Health, Research Triangle 19 Park, NC, United States 20 21 * Correspondence: 22 1. Chih-Fen Hu, Department of Pediatrics, Tri-Service General Hospital, National 23 Defense Medical Center, Taipei 114, Taiwan, Email: 24 [email protected]; [email protected] 25 2. San-Pin Wu, Reproductive and Developmental Biology Laboratory, National 26 Institute of Environmental Health Sciences, National Institutes of Health, 27 Research Triangle Park, NC 27709, United States, Email: 28 [email protected] 29 30 31 32 33 Funding information: This research was funded by Tri-Service General Hospital, 34 grant number TSGH-C108-021 (C.F.H.), TSGH-C108-022 (C.F.H.) and National 35 Institutes of Health GM129374 (G.W.G.L.), Z99-ES999999 (S.P.W.). 36 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.15.993113; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 37 Abstract 38 DYT1 dystonia is a neurological movement disorder characterized by painful 39 sustained muscle contractions resulting in abnormal twisting and postures. In a 40 subset of patients, it is caused by a loss-of-function mutation (ΔE302/303; or ΔE) in 41 the luminal ATPases associated with various cellular activities (AAA+) protein 42 torsinA encoded by the TOR1A gene. The low penetrance of the ΔE mutation (~30- 43 40%) suggests the existence of unknown genetic modifiers of DYT1 dystonia. To 44 identify these modifiers, we performed whole exome sequencing (WES) of blood 45 leukocyte DNA isolated from two DYT1 dystonia patients, three asymptomatic 46 carriers of the ΔE mutation, and an unaffected adult relative. A total of 264 DYT1 47 dystonia-associated variants (DYT1 variants) were identified in 195 genes. 48 Consistent with the emerging view of torsinA as an important regulator of the 49 cytoskeleton, endoplasmic reticulum homeostasis, and lipid metabolism, we found 50 DYT1 variants in genes that encode proteins implicated in these processes. 51 Moreover, 40 DYT1 variants were detected in 32 genes associated with 52 neuromuscular and neuropsychiatric disorders. The DYT1 variants described in this 53 work represent exciting new targets for future studies designed to increase our 54 understanding of the pathophysiology and pathogenesis of DYT1 dystonia. 55 56 57 58 59 60 Keywords: DYT1 dystonia; TOR1A; torsinA; neurogenetics; whole exome 61 sequencing 2 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.15.993113; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 62 1. INTRODUCTION 63 Dystonias are a heterogeneous collection of hyperkinetic neurological movement 64 disorders that are characterized by involuntary muscle contractions resulting in 65 abnormal repetitive movements and postures (Alberto Albanese et al., 2013; Fahn, 66 1988). Dystonias can be acquired as the result of environmental insults (i.e. central 67 nervous system infection, toxins, and traumatic brain injury) (Alberto Albanese et al., 68 2013; A. Albanese, Di Giovanni, & Lalli, 2019) as well as inherited due to genetic 69 mutations (Weisheit, Pappas, & Dauer, 2018). While several causative genes are 70 known, the mechanisms underlying their contribution to dystonia pathogenesis 71 and/or pathophysiology remain unclear. 72 73 Early onset torsion dystonia, or DYT1 dystonia, is the most common and severe 74 inherited dystonia (Petrucci & Valente, 2013). It is a primary torsion dystonia, as 75 dystonia is the only clinical symptom present in patients and it is inherited in a 76 monogenic fashion. The majority of DYT1 dystonia cases are caused by the 77 autosomal dominantly inherited deletion of a GAG codon 78 (c.904_906/907_909ΔGAG) from the TOR1A gene, which removes a glutamic acid 79 residue (ΔE302/303; or ΔE) from the C-terminus of the encoded luminal ATPase 80 torsinA (Neuwald, Aravind, Spouge, & Koonin, 1999; L. J. Ozelius et al., 1997). The 81 ΔE mutation is considered a loss-of-function mutation because homozygous torsinA- 82 knockout and homozygous torsinAΔE-knockin mice both die perinatally and exhibit 83 neurons with abnormal blebbing of the inner nuclear membrane into the perinuclear 84 space of the nuclear envelope (Goodchild, Kim, & Dauer, 2005). In addition, the ΔE 85 mutation impairs the ability of torsinA to interact with its major binding partners the 86 inner nuclear membrane protein lamina-associated polypeptide 1 (LAP1) and the 3 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.15.993113; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 87 endoplasmic reticulum/outer nuclear membrane protein luminal domain-like LAP1 88 (LULL1) (Naismith, Dalal, & Hanson, 2009), which stimulates the ability of torsinA to 89 hydrolyze ATP above negligible background levels in vitro (Zhao, Brown, Chase, 90 Eisele, & Schlieker, 2013). 91 92 Surprisingly, only ~30-40% of individuals heterozygous for the ΔE develop DYT1 93 dystonia despite the presence of abnormalities in brain metabolism and the 94 cerebellothalamocortical pathway in all carriers (Argyelan et al., 2009; Eidelberg et 95 al., 1998; Niethammer, Carbon, Argyelan, & Eidelberg, 2011; Premi et al., 2016; 96 Trost et al., 2002). Collectively, these clinical findings demonstrate that the presence 97 of the ΔE mutation results in abnormal brain function regardless of whether or not 98 an individual develops DYT1 dystonia. Moreover, they suggest the hypothesis that 99 the penetrance of the ΔE mutation may be influenced by additional as-of-yet 100 unknown genetic factors. 101 102 Consistent with this hypothesis, recent research shows that genetic background 103 modulates the phenotype of a mouse model of DYT1 dystonia (Tanabe, Martin, & 104 Dauer, 2012). In addition, expression profiling in peripheral blood harvested from 105 human DYT1 dystonia patients harboring the ΔE mutation and asymptomatic 106 carriers revealed a genetic signature that could correctly predict disease state 107 (Walter et al., 2010). The functional classification of transcripts that were differentially 108 regulated in DYT1 dystonia patients relative to unaffected carriers identified a variety 109 of potentially impacted biological pathways, including cell adhesion, cytoskeleton 110 organization and biogenesis, development of the nervous system, G-protein receptor 111 signaling, and vesicle-mediated pathway/protein transport. Since these biological 4 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.15.993113; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 112 pathways have all been previously associated with torsinA function (Cascalho, 113 Jacquemyn, & Goodchild, 2017; Gonzalez-Alegre, 2019; Laudermilch & Schlieker, 114 2016; Weisheit et al., 2018), we hypothesize that the penetrance of the ΔE mutation 115 and therefore the development of DYT1 dystonia may depend upon the presence or 116 absence of variants in genes that encode proteins that influence biological pathways 117 associated with torsinA function. Below, we describe the use of WES to identify 118 genetic variants in DYT1 dystonia patients but neither unaffected ΔE mutation 119 carriers nor the unaffected control. 120 121 2. MATERIALS AND METHODS 122 2.1 Human Subjects. This study recruited 11 human subjects, including two patients 123 from two separate families of Taiwanese ancestry. All subjects (or legal guardians) 124 gave their written informed consent for participation and the study was approved by 125 the Institutional Review Board of the Tri-Service General Hospital at the National 126 Defense Medical Center in Taipei, Taiwan (IRB# 1-107-05-164). Detailed clinical 127 information was obtained from corresponding clinicians and medical records. 128 129 2.2 Purification of genomic DNA from Isolated Human Blood Leukocytes. 130 Genomic DNA was purified from human leukocytes using the MagPurix®
Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
    [Show full text]
  • Unc93b Antibody (Pab)
    21.10.2014Unc93b antibody (pAb) Rabbit Anti -Human/Mouse/Rat Unc93b Instruction Manual Catalog Number PK-AB718-4553 Synonyms Unc93b Antibody: Unc93b1, homolog of C. elegans Unc93 Description The endoplasmic reticulum (ER) protein Unc93b, a human homolog of the C. elegans Unc93 gene, was initially identified by a forward genetic screen using N-ethyl-N-nitrosourea where a histidine- to-arginine substitution in Unc93b caused defects in Toll-like receptor (TLR) 3, 7 and 9 signaling. Unlike Unc93a, another homolog of the C. elegans Unc93 gene whose function is unknown, Unc93b specifically interacts with TLR3, 7 and 9; the histidine-to-arginine point mutation used to identify Unc93b abolishes this interaction. Mice carrying this point mutation are highly susceptible to infection with a number of viruses, indicating that Unc93b plays an important role in innate immunity. Multiple isoforms of Unc93a are known to exist. This antibody will not cross-react with Unc93a. Quantity 100 µg Source / Host Rabbit Immunogen Unc93b antibody was raised in rabbits against a 19 amino acid peptide from near the amino terminus of human Unc93b. Purification Method Affinity chromatography purified via peptide column. Clone / IgG Subtype Polyclonal antibody Species Reactivity Human, Mouse, Rat Specificity Multiple isoforms of Unc93a are known to exist. This antibody will not cross-react with Unc93a. Formulation Antibody is supplied in PBS containing 0.02% sodium azide. Reconstitution During shipment, small volumes of antibody will occasionally become entrapped in the seal of the product vial. For products with volumes of 200 μl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap.
    [Show full text]
  • Regulation of Cdc42 and Its Effectors in Epithelial Morphogenesis Franck Pichaud1,2,*, Rhian F
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs217869. doi:10.1242/jcs.217869 REVIEW SUBJECT COLLECTION: ADHESION Regulation of Cdc42 and its effectors in epithelial morphogenesis Franck Pichaud1,2,*, Rhian F. Walther1 and Francisca Nunes de Almeida1 ABSTRACT An overview of Cdc42 Cdc42 – a member of the small Rho GTPase family – regulates cell Cdc42 was discovered in yeast and belongs to a large family of small – polarity across organisms from yeast to humans. It is an essential (20 30 kDa) GTP-binding proteins (Adams et al., 1990; Johnson regulator of polarized morphogenesis in epithelial cells, through and Pringle, 1990). It is part of the Ras-homologous Rho subfamily coordination of apical membrane morphogenesis, lumen formation and of GTPases, of which there are 20 members in humans, including junction maturation. In parallel, work in yeast and Caenorhabditis elegans the RhoA and Rac GTPases, (Hall, 2012). Rho, Rac and Cdc42 has provided important clues as to how this molecular switch can homologues are found in all eukaryotes, except for plants, which do generate and regulate polarity through localized activation or inhibition, not have a clear homologue for Cdc42. Together, the function of and cytoskeleton regulation. Recent studies have revealed how Rho GTPases influences most, if not all, cellular processes. important and complex these regulations can be during epithelial In the early 1990s, seminal work from Alan Hall and his morphogenesis. This complexity is mirrored by the fact that Cdc42 can collaborators identified Rho, Rac and Cdc42 as main regulators of exert its function through many effector proteins.
    [Show full text]
  • Defining Functional Interactions During Biogenesis of Epithelial Junctions
    ARTICLE Received 11 Dec 2015 | Accepted 13 Oct 2016 | Published 6 Dec 2016 | Updated 5 Jan 2017 DOI: 10.1038/ncomms13542 OPEN Defining functional interactions during biogenesis of epithelial junctions J.C. Erasmus1,*, S. Bruche1,*,w, L. Pizarro1,2,*, N. Maimari1,3,*, T. Poggioli1,w, C. Tomlinson4,J.Lees5, I. Zalivina1,w, A. Wheeler1,w, A. Alberts6, A. Russo2 & V.M.M. Braga1 In spite of extensive recent progress, a comprehensive understanding of how actin cytoskeleton remodelling supports stable junctions remains to be established. Here we design a platform that integrates actin functions with optimized phenotypic clustering and identify new cytoskeletal proteins, their functional hierarchy and pathways that modulate E-cadherin adhesion. Depletion of EEF1A, an actin bundling protein, increases E-cadherin levels at junctions without a corresponding reinforcement of cell–cell contacts. This unexpected result reflects a more dynamic and mobile junctional actin in EEF1A-depleted cells. A partner for EEF1A in cadherin contact maintenance is the formin DIAPH2, which interacts with EEF1A. In contrast, depletion of either the endocytic regulator TRIP10 or the Rho GTPase activator VAV2 reduces E-cadherin levels at junctions. TRIP10 binds to and requires VAV2 function for its junctional localization. Overall, we present new conceptual insights on junction stabilization, which integrate known and novel pathways with impact for epithelial morphogenesis, homeostasis and diseases. 1 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. 2 Computing Department, Imperial College London, London SW7 2AZ, UK. 3 Bioengineering Department, Faculty of Engineering, Imperial College London, London SW7 2AZ, UK. 4 Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Comparison of Orthologs Across Multiple Species by Various Strategies
    COMPARISON OF ORTHOLOGS ACROSS MULTIPLE SPECIES BY VARIOUS STRATEGIES BY HUI LIU DISSERTATION Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biophysics and Computational Biology in the Graduate College of the University of Illinois at Urbana-Champaign, 2014 Urbana, Illinois Doctoral Committee: Professor Eric Jakobsson, Chair, Director of Research Professor Gene E. Robinson Associate Professor Saurabh Sinha Assistant Professor Jian Ma Abstract Thanks to the improvement of genome sequencing technology, abundant multi-species genomic data now became available and comparative genomics continues to be a fast prospering filed of biological research. Through the comparison of genomes of different organisms, we can understand what, at the molecular level, distinguishes different life forms from each other. It shed light on revealing the evolution of biology. And it also helps to refine the annotations and functions of individual genomes. For example, through comparisons across mammalian genomes, we can give an estimate of the conserved set of genes across mammals and correspondingly, find the species-specific sets of genes or functions. However, comparative genomics can be feasible only if a meaningful classification of genes exists. A natural way to do so is to delineate sets of orthologous genes. However, debates exist about the appropriate way to define orthologs. It is originally defined as genes in different species which derive from speciation events. But such definition is not sufficient to derive orthologous genes due to the complexity of evolutionary events such as gene duplication and gene loss. While it is possible to correctly figure out all the evolutionary events with the true phylogenetic tree, the true phylogenetic tree itself is impractical to be inferred.
    [Show full text]
  • Kif9 Is an Active Kinesin Motor Required for Ciliary Beating and Proximodistal Patterning of Motile Axonemes
    bioRxiv preprint doi: https://doi.org/10.1101/2021.08.26.457815; this version posted August 27, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Kif9 is an active kinesin motor required for ciliary beating and proximodistal patterning of motile axonemes Mia J. Konjikusic1,2,3, Chanjae Lee1, Yang Yue4, Bikram D. Shrestha5, Ange M. Nguimtsop1, Amjad Horani6, Steven Brody7,8, Vivek N. Prakash5,9, Ryan S. Gray2,3, Kristen J. Verhey4, John B. Wallingford1* 1 Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA. 2 Department of Pediatrics, Dell Pediatric Research Institute, 1400 Barbara Jordan Blvd, The University of Texas at Austin, Dell Medical School, Austin, TX, USA. 3 Department of Nutritional Sciences, 200 W 24th Street, The University of Texas at Austin, Austin, TX 78712, USA. 4 Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA. 5 Department of Physics, University of Miami, Coral Gables, FL, USA. 6 Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA. 7 Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. 8 Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, 63110 USA 9 Department of Biology and Department of Marine Biology and Ecology, University of Miami, Coral Gables, FL, USA. *Corresponding Author [email protected] Patterson Labs 2401 Speedway Austin, Tx 78712 bioRxiv preprint doi: https://doi.org/10.1101/2021.08.26.457815; this version posted August 27, 2021.
    [Show full text]
  • Massive Parallel Sequencing in a Family with Rectal Cancer
    Wallander et al. Hereditary Cancer in Clinical Practice (2021) 19:23 https://doi.org/10.1186/s13053-021-00181-2 RESEARCH Open Access Massive parallel sequencing in a family with rectal cancer Karin Wallander1,2 , Jessada Thutkawkorapin1 , Ellika Sahlin1,2 , Annika Lindblom1,2* and Kristina Lagerstedt-Robinson1,2 Abstract Background: We have previously reported a family with a suspected autosomal dominant rectal and gastric cancer syndrome without any obvious causative genetic variant. Here, we focused the study on a potentially isolated rectal cancer syndrome in this family. Methods: We included seven family members (six obligate carriers). Whole-exome sequencing and whole-genome sequencing data were analyzed and filtered for shared coding and splicing sequence and structural variants among the affected individuals. Results: When considering family members with rectal cancer or advanced adenomas as affected, we found six new potentially cancer-associated variants in the genes CENPB, ZBTB20, CLINK, LRRC26, TRPM1, and NPEPL1. All variants were missense variants and none of the genes have previously been linked to inherited rectal cancer. No structural variant was found. Conclusion: By massive parallel sequencing in a family suspected of carrying a highly penetrant rectal cancer predisposing genetic variant, we found six genetic missense variants with a potential connection to the rectal cancer in this family. One of them could be a high-risk genetic variant, or one or more of them could be low risk variants. The p.(Glu438Lys) variant in the CENPB gene was found to be of particular interest. The CENPB protein binds DNA and helps form centromeres during mitosis. It is involved in the WNT signaling pathway, which is critical for colorectal cancer development and its role in inherited rectal cancer needs to be further examined.
    [Show full text]
  • Genetic Diagnosis and Respiratory Management Of
    UITNODIGING GENETIC DIAGNOSIS Voor het bijwonen van de openbare verdediging van AND RESPIRATORY het proefschrift Genetic diagnosis and respiratory management of primary ciliary dyskinesia dyskinesia ciliary of primary management respiratory and diagnosis Genetic GENETIC DIAGNOSIS MANAGEMENT OF AND RESPIRATORY MANAGEMENT OF PRIMARY CILIARY PRIMARY CILIARY DYSKINESIA DYSKINESIA Door Tamara Paff Tamara Paff dinsdag 7 november 2017 11:45 uur in de aula van de Vrije Universiteit de Boelelaan, 1105 TE Amsterdam Receptie aansluitend in Grand cafe The Basket op de VU campus Tamara Paff Johann Keplerstraat 8-1 hoog 1098 HL, Amsterdam +31645364292/ [email protected] Tamara Paff Tamara | Paranimfen Marian van der Meij [email protected] 06-15500488 Marc van der Schee [email protected] 06-40883602 14759 - Paff_R11,5_OMS_DEF.indd 1 25-09-17 10:25 UITNODIGING GENETIC DIAGNOSIS Voor het bijwonen van de openbare verdediging van AND RESPIRATORY het proefschrift Genetic diagnosis and respiratory management of primary ciliary dyskinesia dyskinesia ciliary of primary management respiratory and diagnosis Genetic GENETIC DIAGNOSIS MANAGEMENT OF AND RESPIRATORY MANAGEMENT OF PRIMARY CILIARY PRIMARY CILIARY DYSKINESIA DYSKINESIA Door Tamara Paff Tamara Paff Dag datum tijdstip in de aula van de Vrije Universiteit de Boelelaan, 1105 TE Amsterdam Receptie aansluitend in Grand cafe The Basket op de VU campus Tamara Paff Johann Keplerstraat 8-1 hoog 1098 HL, Amsterdam +31645364292/ [email protected] Tamara Paff Tamara Paranimfen Marian van der Meij | [email protected] 06-15500488 Marc van der Schee [email protected] 06-40883602 14759_TPaff_BW.indd 1 19-09-17 13:08 ProefschriftTamaraPaff_Cover+Bladwijzer.indd All Pages 15-08-17 12:47 The studies performed in this thesis were financially supported by the PCD support group (PCD belangengroep), Fonds NutsOhra, the “Dutch mudder” team and Chiesi.
    [Show full text]
  • Next-Gen Sequencing Identifies Non-Coding Variation Disrupting
    OPEN Molecular Psychiatry (2018) 23, 1375–1384 www.nature.com/mp ORIGINAL ARTICLE Next-gen sequencing identifies non-coding variation disrupting miRNA-binding sites in neurological disorders P Devanna1, XS Chen2,JHo1,2, D Gajewski1, SD Smith3, A Gialluisi2,4, C Francks2,5, SE Fisher2,5, DF Newbury6,7 and SC Vernes1,5 Understanding the genetic factors underlying neurodevelopmental and neuropsychiatric disorders is a major challenge given their prevalence and potential severity for quality of life. While large-scale genomic screens have made major advances in this area, for many disorders the genetic underpinnings are complex and poorly understood. To date the field has focused predominantly on protein coding variation, but given the importance of tightly controlled gene expression for normal brain development and disorder, variation that affects non-coding regulatory regions of the genome is likely to play an important role in these phenotypes. Herein we show the importance of 3 prime untranslated region (3'UTR) non-coding regulatory variants across neurodevelopmental and neuropsychiatric disorders. We devised a pipeline for identifying and functionally validating putatively pathogenic variants from next generation sequencing (NGS) data. We applied this pipeline to a cohort of children with severe specific language impairment (SLI) and identified a functional, SLI-associated variant affecting gene regulation in cells and post-mortem human brain. This variant and the affected gene (ARHGEF39) represent new putative risk factors for SLI. Furthermore, we identified 3′UTR regulatory variants across autism, schizophrenia and bipolar disorder NGS cohorts demonstrating their impact on neurodevelopmental and neuropsychiatric disorders. Our findings show the importance of investigating non-coding regulatory variants when determining risk factors contributing to neurodevelopmental and neuropsychiatric disorders.
    [Show full text]
  • Supplemental Table 1: Genes That Show Altered Expression in Hepg2 Cells in the Presence of Exogenously Added Let-7
    Supplemental Table 1: Genes that show altered expression in HepG2 cells in the presence of exogenously added let-7 Gene Title Gene Symbol RefSeq Transcriptp- IDvalue(TREAp-TMENTvalue(Let7bS) - negativLog2 Reatio control1) (Let7b - negativp-value(Let7be control1) - negativLog2 Reatio control2) (Let7b - negative control2) aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) AKR1D1 NM_005989 3.28E-12 2.52E-12 -3.85007 3.59E-12 -3.73727 lin-28 homolog B (C. elegans) LIN28B NM_001004317 6.13E-15 8.29E-15 -3.29879 1.55E-15 -3.79656 high mobility group AT-hook 2 /// high mobility group AT-hook 2 HMGA2 NM_001015886 /// NM_0034833.74E-14 /// NM_0034844.29E-14 -3.06085 4.56E-14 -3.04538 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 HECW2 NM_020760 1.27E-13 6.65E-13 -2.94724 4.47E-12 -2.50907 cell division cycle 25A CDC25A NM_001789 /// NM_2015672.01E-11 7.32E-11 -2.88831 1.99E-11 -3.22735 hypothetical protein FLJ21986 FLJ21986 NM_024913 1.05E-09 5.19E-10 -2.80277 1.18E-09 -2.61084 solute carrier family 2 (facilitated glucose transporter), member 3 SLC2A3 NM_006931 1.59E-13 3.49E-13 -2.78111 1.84E-12 -2.41734 Transcribed locus --- --- 2.58E-13 1.08E-13 -2.59794 1.69E-13 -2.50248 Hypothetical protein LOC145786 LOC145786 --- 4.23E-12 1.07E-11 -2.58849 3.00E-12 -2.88135 Dicer1, Dcr-1 homolog (Drosophila) DICER1 NM_030621 /// NM_1774381.06E-08 4.37E-09 -2.5442 4.49E-09 -2.53796 mannose-binding lectin (protein C) 2, soluble (opsonic defect) MBL2 NM_000242 9.73E-10 1.48E-09 -2.53211 9.84E-10 -2.62363 cell
    [Show full text]
  • Supplementary Figures and Tables Figure S1. (A) Heat Map Displaying
    Supplementary Figures and Tables Figure S1. (A) Heat map displaying 526 DEGs derived from GSE14827 between metastasis and non-metastasis patients. (B) Heat map displaying 1057 DEGs derived from GSE39055 between recurrence and non-recurrence patients. Rows represent genes and columns represent patients. Red rectangles represent patients with metastasis or recurrence and blue rectangles represent patients without metastasis or recurrence. Figure S2. (A) Dot plots of PQBP1and PCK2 expression in 3 datasets. the red dots represented patients who died during the follow-up and the blue dots represented patients were alive during follow-up. (B) Density plots of PQBP1and PCK2 expression in 3 datasets, the red lines represented expression distributions in patients who died during the follow-up, and the blue lines in patients were alive during follow-up, and the black lines in all patients. (C) Kaplan-Meier curves of PQBP1, PCK2 expression status and combination status of them on overall survival in GSE21257. Table S3. The intersected DEGs identified in 2 discovery datasets. Table S4. Associations of PCK2 and PQBP1 expression status with clinicopathological features of OS patients in GSE14827, GSE39055 and GSE21257. Table S5. Univariate and multivariate Cox regression analyses for overall survival of OS patients in GSE21257. Figure S1 Figure S2 Table S3. The intersected DEGs identified in 2 discovery datasets. GSE14827 GSE39055 Gene Symbol p value Fold Change p value Fold Change Up-regulated ASGR1 0.001184122 2.344428863 0.039400673 1.621460858 ZNF418
    [Show full text]